University of Saskatchewan

Cancer Research Cluster

New Publication from Xiang Lab in Breast Cancer Res Treat

"Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice"

Authors: Wang L, Xie Y, Ahmed KA, Ahmed S, Sami A, Chibbar R, Xu Q, Kane SE, Hao S, Mulligan SJ, Xiang J.
Breast Cancer Res Treat. 2013 Jul;140(2):273-84. PMID: 23881522

The paper can be accessed here: http://www.ncbi.nlm.nih.gov/pubmed/23881522

Share on Google+